Nothing Special   »   [go: up one dir, main page]

EA200600456A1 - Новый способ синтеза периндоприла и его фармацевтически приемлемых солей - Google Patents

Новый способ синтеза периндоприла и его фармацевтически приемлемых солей

Info

Publication number
EA200600456A1
EA200600456A1 EA200600456A EA200600456A EA200600456A1 EA 200600456 A1 EA200600456 A1 EA 200600456A1 EA 200600456 A EA200600456 A EA 200600456A EA 200600456 A EA200600456 A EA 200600456A EA 200600456 A1 EA200600456 A1 EA 200600456A1
Authority
EA
Eurasian Patent Office
Prior art keywords
perindopril
synthesis
pharmaceutically acceptable
acceptable salts
new method
Prior art date
Application number
EA200600456A
Other languages
English (en)
Other versions
EA008485B1 (ru
Inventor
Тьерри Дюбюффе
Жан-Пьер Лекув
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA200600456A1 publication Critical patent/EA200600456A1/ru
Publication of EA008485B1 publication Critical patent/EA008485B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Способ синтеза периндоприла формулы (I)и его фармацевтически приемлемых солей.
EA200600456A 2003-08-29 2004-08-27 Новый способ синтеза периндоприла и его фармацевтически приемлемых солей EA008485B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03292131A EP1380590B1 (fr) 2003-08-29 2003-08-29 Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables
PCT/FR2004/002196 WO2005023841A1 (fr) 2003-08-29 2004-08-27 Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables

Publications (2)

Publication Number Publication Date
EA200600456A1 true EA200600456A1 (ru) 2006-08-25
EA008485B1 EA008485B1 (ru) 2007-06-29

Family

ID=29724623

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600456A EA008485B1 (ru) 2003-08-29 2004-08-27 Новый способ синтеза периндоприла и его фармацевтически приемлемых солей

Country Status (20)

Country Link
US (1) US7183308B1 (ru)
EP (1) EP1380590B1 (ru)
JP (1) JP4331205B2 (ru)
CN (1) CN100395264C (ru)
AR (1) AR045515A1 (ru)
AT (1) ATE338766T1 (ru)
AU (1) AU2004270427B2 (ru)
CY (1) CY1105790T1 (ru)
DE (1) DE60308102T2 (ru)
DK (1) DK1380590T3 (ru)
EA (1) EA008485B1 (ru)
ES (1) ES2272922T3 (ru)
HK (1) HK1096409A1 (ru)
MY (1) MY139348A (ru)
NZ (1) NZ545335A (ru)
PL (1) PL211509B1 (ru)
PT (1) PT1380590E (ru)
SI (1) SI1380590T1 (ru)
WO (1) WO2005023841A1 (ru)
ZA (1) ZA200601428B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1380591B1 (fr) * 2003-08-29 2005-11-16 Les Laboratoires Servier Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables
WO2005108365A1 (en) * 2004-05-07 2005-11-17 Glenmark Pharmaceuticals Limited Processes for the preparation of alpha polymorph of perindopril erbumine
SI1679072T1 (sl) 2005-01-06 2009-02-28 Ipca Lab Ltd Postopek za sintezo derivatov (2S,3aS,7aS)-1-(S)-alanil-oktahidro-1H-indol-2-karboksilne kisline inuporaba v sintezi perindoprila
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.
CN108752259A (zh) * 2018-07-04 2018-11-06 南京方生和医药科技有限公司 培哚普利消旋体及其中间体的制备方法
CN112047998B (zh) * 2020-09-07 2024-01-09 上海阿达玛斯试剂有限公司 一种培哚普利的制备方法
CN113980096A (zh) * 2021-11-29 2022-01-28 绍兴市上虞区武汉理工大学高等研究院 一种吨级培哚普利叔丁胺的合成工艺方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
DK1319668T3 (da) * 2003-03-12 2005-02-14 Servier Lab Fremgangsmåde til syntese af (2S, 3aS, 7aS)-1-((S)-alanyl)-octahydro-1H-indol-2-carboxylsyrederivater og anvendelse heraf ved syntese af perindopril
EP1321471B1 (fr) * 2003-03-12 2005-05-04 Les Laboratoires Servier Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables
EP1371659B1 (fr) * 2003-08-29 2005-10-12 Les Laboratoires Servier Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables

Also Published As

Publication number Publication date
AR045515A1 (es) 2005-11-02
PL211509B1 (pl) 2012-05-31
ATE338766T1 (de) 2006-09-15
ES2272922T3 (es) 2007-05-01
CN100395264C (zh) 2008-06-18
SI1380590T1 (sl) 2006-12-31
DE60308102T2 (de) 2007-06-21
DK1380590T3 (da) 2007-01-08
DE60308102D1 (de) 2006-10-19
EP1380590A1 (fr) 2004-01-14
US20070043103A1 (en) 2007-02-22
CN1839147A (zh) 2006-09-27
EP1380590B1 (fr) 2006-09-06
PL379629A1 (pl) 2006-10-30
AU2004270427A1 (en) 2005-03-17
WO2005023841A1 (fr) 2005-03-17
NZ545335A (en) 2009-08-28
MY139348A (en) 2009-09-30
HK1096409A1 (en) 2007-06-01
EA008485B1 (ru) 2007-06-29
PT1380590E (pt) 2006-12-29
US7183308B1 (en) 2007-02-27
JP4331205B2 (ja) 2009-09-16
JP2007526901A (ja) 2007-09-20
AU2004270427B2 (en) 2008-08-21
CY1105790T1 (el) 2011-02-02
ZA200601428B (en) 2007-05-30

Similar Documents

Publication Publication Date Title
EA200201057A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
ATE377004T1 (de) Proteinkinaseinhibitoren
DE60331187D1 (de) Kinaseinhibitoren
CY1106471T1 (el) Νεα μεθοδος συνθεσης της περινδροπριλης και των φαρμακευτικως αποδεκτων αλατων αυτης
EA200800760A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
EA201200669A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
CY1106544T1 (el) Μεθοδος συνθεσεως υπερινδοπριλης και τα φαρμακευτικως αποδεκτα αλατα αυτης
EA200601686A1 (ru) Замещенные производные морфолина и тиоморфолина
EA200501925A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200501557A1 (ru) Новый способ синтеза (2s)-индолин-2-карбоновой кислоты и использование в синтезе периндоприла
CY1108238T1 (el) Μεθοδος συνθεσης της περινδοπριλης και των φαρμακευτικως αποδεκτων αλατων της
EA200600456A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200600455A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200600454A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
MY135359A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
EA200501258A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200600249A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200600250A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200501299A1 (ru) Замещенные производные анилина
CY1106543T1 (el) Μεθοδος συνθεσεως υπερινδοπριλης και τα φαρμακευτικως αποδεκτα αλατα αυτης
EA200501256A1 (ru) НОВЫЙ СПОСОБ СИНТЕЗА (2S,3aS,7aS)-ПЕРГИДРОИНДОЛ-2-КАРБОНОВОЙ КИСЛОТЫ И ЕЁ СЛОЖНЫХ ЭФИРОВ, А ТАКЖЕ ИХ ПРИМЕНЕНИЕ ДЛЯ СИНТЕЗА ПЕРИНДОПРИЛА
EA200501499A1 (ru) ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ п-ДИАМИНОБЕНЗОЛА
EA200501669A1 (ru) Замещенные производные индолина и индола
MY137288A (en) New process for the synthesis of n-[(s)-1-ethoxycarbonylbutyl]-(s)-alanine and application in the synthesis of perindopril
MY137391A (en) New process for the synthesis of n-[(s)-1-ethoxycarbonylbutyl]-(s)-alanine and application in the synthesis of perindopril

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU